206 related articles for article (PubMed ID: 19042066)
1. [Treatment of HIV facial lipoatrophy with a submalar porous polyethylene implant (Medpor)].
Claude O; Domergue Than Trong E; Blanc R; Ascher B; Bagot M; Meningaud JP; Lantieri L
Ann Chir Plast Esthet; 2009 Feb; 54(1):21-8. PubMed ID: 19042066
[TBL] [Abstract][Full Text] [Related]
2. Facial reconstruction using porous high-density polyethylene (medpor): long-term results.
Niechajev I
Aesthetic Plast Surg; 2012 Aug; 36(4):917-27. PubMed ID: 22684610
[TBL] [Abstract][Full Text] [Related]
3. Malar, submalar, and midfacial implants.
Constantinides MS; Galli SK; Miller PJ; Adamson PA
Facial Plast Surg; 2000; 16(1):35-44. PubMed ID: 11802345
[TBL] [Abstract][Full Text] [Related]
4. Contemporary surgical management of HIV-associated facial lipoatrophy.
Funk E; Bressler FJ; Brissett AE
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1015-22. PubMed ID: 16730549
[TBL] [Abstract][Full Text] [Related]
5. A comparison of lipoatrophy and aging: volume deficits in the face.
Coleman S; Saboeiro A; Sengelmann R
Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
[TBL] [Abstract][Full Text] [Related]
6. Restorative interventions for HIV facial lipoatrophy.
Carey D; Liew S; Emery S
AIDS Rev; 2008; 10(2):116-24. PubMed ID: 18615122
[TBL] [Abstract][Full Text] [Related]
7. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.
Karim RB; de Lint CA; van Galen SR; van Rozelaar L; Nieuwkerk PT; Askarizadeh E; Hage JJ
Aesthetic Plast Surg; 2008 Nov; 32(6):873-8. PubMed ID: 18551339
[TBL] [Abstract][Full Text] [Related]
9. Midface volume replacement with a transmaxillary implant.
Burres S
Aesthetic Plast Surg; 2005; 29(1):1-4; discussion 5. PubMed ID: 15580433
[TBL] [Abstract][Full Text] [Related]
10. Approaches to treatment of HIV facial lipoatrophy.
Jones D
Skin Therapy Lett; 2005 Nov; 10(9):5-7. PubMed ID: 16292459
[TBL] [Abstract][Full Text] [Related]
11. Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants.
Mori A; Lo Russo G; Agostini T; Pattarino J; Vichi F; Dini M
J Plast Reconstr Aesthet Surg; 2006; 59(11):1209-16. PubMed ID: 17046631
[TBL] [Abstract][Full Text] [Related]
12. Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients.
Rauso R; Curinga G; Santillo V; Corvo G; Tartaro G
J Craniofac Surg; 2011 Sep; 22(5):1684-8. PubMed ID: 21959413
[TBL] [Abstract][Full Text] [Related]
13. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients.
Loutfy MR; Raboud JM; Antoniou T; Kovacs C; Shen S; Halpenny R; Ellenor D; Ezekiel D; Zhao A; Beninger F
AIDS; 2007 May; 21(9):1147-55. PubMed ID: 17502725
[TBL] [Abstract][Full Text] [Related]
14. Preliminary experiences with Bio-Alcamid in HIV facial lipoatrophy.
Ramon Y; Fodor L; Ullmann Y
Dermatology; 2007; 214(2):151-4. PubMed ID: 17341865
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid new formulation: experience in HIV-associated facial lipoatrophy.
Bechara FG; Gambichler T; Brockmeyer NH; Sand M; Altmeyer P; Hoffmann K
Dermatology; 2008; 217(3):244-9. PubMed ID: 18663308
[TBL] [Abstract][Full Text] [Related]
16. Malar and submalar augmentation.
Binder WJ; Azizzadeh B
Facial Plast Surg Clin North Am; 2008 Feb; 16(1):11-32, v. PubMed ID: 18063245
[TBL] [Abstract][Full Text] [Related]
17. E-M shaped septal encircling with Medpor reconstruction on crooked noses: personal technique and postoperative results.
Emsen IM
J Craniofac Surg; 2008 Jan; 19(1):216-26. PubMed ID: 18216692
[TBL] [Abstract][Full Text] [Related]
18. High density porous polyethylene material (Medpor) as an unwrapped orbital implant.
Chen YH; Cui HG
J Zhejiang Univ Sci B; 2006 Aug; 7(8):679-82. PubMed ID: 16845724
[TBL] [Abstract][Full Text] [Related]
19. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.
Silvers SL; Eviatar JA; Echavez MI; Pappas AL
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):34S-45S. PubMed ID: 16936543
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of facial lipoatrophy by lipofilling in HIV infected patients: retrospective study on 317 patients on 9 years].
Uzzan C; Boccara D; Lacheré A; Mimoun M; Chaouat M
Ann Chir Plast Esthet; 2012 Jun; 57(3):210-6. PubMed ID: 22218365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
